Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-07

Clinical Trial Update: A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers [NA]

View source ↗

Summary

A feasibility study update on plasma/nitric oxide therapy for diabetic foot ulcers, sponsored by Origin Inc.; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plasma/Nitric Oxide Therapy

Snippet

Sponsor: Origin Inc. | Conditions: Diabetic Foot Ulcer | NA | Status: UNKNOWN